Vote Scores
Filings read through

How funds voted at Horizon Therapeutics Public Limited Company

Filers reporting
692, year to 30 June 2024
Latest meeting on file
Meetings on file
1

In the year to 30 June 2024, 692 filers on Form N-PX reported votes at Horizon Therapeutics Public Limited Company. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 1,032 marks to the ballot items, each with or against management. 57.6% of the marks are with management.

On say-on-pay, 420 of the 646 reporting filers that marked the item voted against management. This is 65.0% of the filers. Of the reported shares, 99.5% went against management. The median of the 3,781 companies on this site with a say-on-pay item is 7.5% of filers and 2.9% of reported shares.

At the meeting of 27 Jul 2023, 13 fund families have a say-on-pay position with management and 36 have a position against management.

By filers reporting in the year to 30 June 2024, Horizon Therapeutics Public Limited Company was number 575 of 11,775 companies with a page and votes in that year. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 38.9% of the vote records at Horizon Therapeutics Public Limited Company. At all companies on this site, it is 12.3%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 27 Jul 2023

691 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    3 nominees. 88.4% of the reported votes are for. 55 filers withheld from or voted against at least one nominee.

    1,146 vote records from 185 filers. 11 of the 185 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 42
    • Against 1
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,012 vote records from 677 filers. 420 of the 646 filers that marked the item voted against management. 31 filers gave no management mark.

    5 filers reported share counts too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 49 fund families
    • For 13
    • Against 36
    • Against management 36
  3. Item 3: Audit-related items (auditor ratification)

    382 vote records from 185 filers. 5 of the 185 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 43
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    59 vote records from 15 filers. 2 of the 15 filers that marked the item voted against management.

  5. Item 5: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 0 of the 1 filer that marked the item voted against management.

Positions of the fund families at the meeting of 27 Jul 2023

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Horizon Therapeutics Public Limited Company, meeting of 27 Jul 2023Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
AllianceBernsteinAgainst, against management
AllspringAgainst, against management
American CenturyAgainst, against management
BairdAgainst, against management
BlackRock and iSharesFor
BNY MellonFor
Brighthouse FundsAgainst, against management
Capital Group and American FundsFor
Charles SchwabAgainst, against management
Columbia ThreadneedleAgainst, against management
DimensionalAgainst, against management
DWSAgainst, against management
EquitableAgainst, against management
Federated HermesFor
FidelityAgainst, against management
First TrustAgainst, against management
Franklin TempletonAgainst, against management
Global XAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
InvescoFor
J.P. MorganFor
Jackson National fundsAgainst, against management
Janus HendersonAgainst, against management
John Hancock and ManulifeAgainst, against management
Lincoln FinancialAgainst, against management
Macquarie and Delaware FundsAgainst, against management
MassMutualFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
NationwideAgainst, against management
Natixis and Loomis SaylesAgainst, against management
Neuberger BermanAgainst, against management
Northern Trust and FlexSharesFor
Nuveen and TIAAFor
Pacific Life fundsFor
PGIM and PrudentialAgainst, against management
PIMCOAgainst, against management
PrincipalAgainst, against management
ProShares and ProFundsAgainst, against management
Russell InvestmentsAgainst, against management
SEIAgainst, against management
State Street and SPDRFor
T. Rowe PriceAgainst, against management
TransamericaAgainst, against management
VanguardFor
Victory CapitalAgainst, against management
VirtusFor
VoyaAgainst, against management
WisdomTreeAgainst, against management

Every meeting on file

Meetings of Horizon Therapeutics Public Limited Company, from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2024691565.0%

Say-on-pay, season by season

Say-on-pay at Horizon Therapeutics Public Limited Company: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202469265.0%99.5%
Horizon Therapeutics Public Limited Company and the median of companies on this site, year to 30 June 2024
Say-on-payThis companyMedian of companies on this site
Filers against management65.0%7.5%
Reported shares against management99.5%2.9%

The median covers 3,781 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Horizon Therapeutics Public Limited Company by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS1,14644.1%
SECTION 14A SAY-ON-PAY VOTES1,01238.9%
AUDIT-RELATED38214.7%
COMPENSATION602.3%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Horizon Therapeutics Public Limited Company. https://votescores.com/company/horizon-therapeutics-public-limited-company/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Horizon Therapeutics Public Limited Company are on file?
1 meeting is on file, on 27 Jul 2023. 1 meeting has 20 or more reporting filers and has its own page.
Did filers report proposals from security holders at Horizon Therapeutics Public Limited Company?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2024. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Horizon Therapeutics Public Limited Company reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Horizon Therapeutics Public Limited Company, grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .